Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23192920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Conditions: Peripheral Artery Disease;   Peripheral Vascular Disease;   Critical Limb Ischemia
Interventions: Biological: CD34-positive cells;   Biological: Saline and 5% autologous plasma

Indicates status has not been verified in more than two years